ZNF232-AS1

Across TCGA pan-cancer cohorts, ZNF232-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ZNF232-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where ZNF232-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types ZNF232-AS1 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KICH, LIHC, and THCA are the cancer types where ZNF232-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF232-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	II,III,IV	−1.595	<.001	11	view →
LIHC	Male	II,III,IV	+1.499	<.001	9	view →
THCA	Male	III,IV	−1.187	<.001	9	view →
KIRC	Male	All	−0.483	<.001	9	view →
UCEC	All	II,III,IV	+0.910	.006	6	view →
BRCA	All	II,III,IV	−0.312	<.001	6	view →
HNSC	All	All	+0.300	.004	5	view →
LUSC	All	All	+0.399	.002	4	view →
CHOL	All	All	+0.966	<.001	3	view →
COAD	All	All	−0.253	.020	2	view →
READ	All	All	−0.585	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

ZNF232-AS1–KICH

Open the KICH breakdown →